Preparation of AS1411 Aptamer Modified Mn-MoS 2 QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma [Corrigendum] 18 27 1 2023 505 507 International Journal of Nanomedicine 10.2147/IJN.S405918 PMC9888302 36733408 Background Early diagnosis of renal cell carcinoma is extremely significant for the effective treatment of kidney cancer.
← all excerpts
Preparation of AS1411 Aptamer Modified Mn-MoS<sub>2</sub> QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma.
1
—
—